/
Other
Phase II Clinical Trial
3
Pipeline Programs↗
8
Active Trials↗
8
Companies Involved↗
Phase II Clinical Trial is an early-stage landscape with 3 programs across 8 companies. The most active players are Shanghai Bao Pharmaceuticals Co., Ltd., Sichuan Enray Pharmaceutical Sciences Company, Dizal Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 23
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
30
clinical trials
Completed12 · 40%
Unknown status6 · 20%
Recruiting5 · 17%
Not yet recruiting3 · 10%
Terminated3 · 10%
Suspended1 · 3%
Clinical Trials
Trial Activity
30 trials
Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC
Completed·—·Phase 2·NCT03573947·46 enrolled
HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00125970·480 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)